Literature DB >> 17442486

Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1.

P J S Vig1, J Wei, Q Shao, M D Hebert, S H Subramony, L T Sutton.   

Abstract

Spinocerebellar ataxia-1 (SCA1) is caused by the expansion of a polyglutamine repeats within the disease protein, ataxin-1. The mutant ataxin-1 precipitates as large intranuclear aggregates in the affected neurons. These aggregates may protect neurons from mutant protein and/or trigger neuronal degeneration by encouraging recruitment of other essential proteins. Our previous studies have shown that calcium binding protein calbindin-D28k (CaB) associated with SCAl pathogenesis is recruited to ataxin-l aggregates in Purkinje cells of SCAl mice. Since our recent findings suggest that tissue transglutaminase 2 (TG2) may be involved in crosslinking and aggregation of ataxin-l, the present study was initiated to determine if TG2 has any role in CaB-ataxin-l interaction. The guinea pig TG2 covalently crosslinked purified rat brain CaB. Time dependent progressive increase in aggregation produced large multimers, which stayed on top of the gel. CaB interaction with ataxin-l was studied using HeLa cell lysates expressing GFP and GFP tagged ataxin-l with normal and expanded polyglutamine repeats (Q2, Q30 and Q82). The reaction products were analyzed by Western blots using anti-polyglutamine, CaB or GFP antibodies. CaB interacted with ataxin-1 independent of TG2 as the protein-protein crosslinker DSS stabilized CaB-ataxin-l complex. TG2 crosslinked CaB preferentially with Q82 ataxin-1. The crosslinking was inhibited with EGTA or TG2 inhibitor cystamine. The present data indicate that CaB may be a TG2 substrate. In addition, aggregates of mutant ataxin-l may recruit CaB via TG2 mediated covalent crosslinking, further supporting the argument that ataxin-l aggregates may be toxic to neurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442486      PMCID: PMC1949022          DOI: 10.1016/j.neulet.2007.04.005

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  33 in total

1.  RNA association and nucleocytoplasmic shuttling by ataxin-1.

Authors:  Stuart Irwin; Mark Vandelft; Deborah Pinchev; Jenny L Howell; Joanna Graczyk; Harry T Orr; Ray Truant
Journal:  J Cell Sci       Date:  2005-01-01       Impact factor: 5.285

2.  Calbindin-D28k in nerve cell nuclei.

Authors:  D C German; M C Ng; C L Liang; A McMahon; A M Iacopino
Journal:  Neuroscience       Date:  1997-12       Impact factor: 3.590

3.  Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.

Authors:  D R D'Souza; J Wei; Q Shao; M D Hebert; S H Subramony; P J S Vig
Journal:  Neurosci Lett       Date:  2006-10-11       Impact factor: 3.046

4.  Distinct nuclear localization and activity of tissue transglutaminase.

Authors:  M Lesort; K Attanavanich; J Zhang; G V Johnson
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

5.  Identification of transglutaminase-reactive residues in S100A11.

Authors:  N A Robinson; R L Eckert
Journal:  J Biol Chem       Date:  1998-01-30       Impact factor: 5.157

6.  Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice.

Authors:  P J Vig; S H Subramony; E N Burright; J D Fratkin; D O McDaniel; D Desaiah; Z Qin
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

7.  Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease.

Authors:  S Y Kim; P Grant; J H Lee; H C Pant; P M Steinert
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

8.  Nuclear translocation of tissue type transglutaminase during sphingosine-induced cell death: a novel aspect of the enzyme with DNA hydrolytic activity.

Authors:  Y Takeuchi; H Ohashi; P J Birckbichler; T Ikejima
Journal:  Z Naturforsch C J Biosci       Date:  1998 May-Jun

9.  Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases.

Authors:  V Gentile; C Sepe; M Calvani; M A Melone; R Cotrufo; A J Cooper; J P Blass; G Peluso
Journal:  Arch Biochem Biophys       Date:  1998-04-15       Impact factor: 4.013

10.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more
  7 in total

1.  Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model.

Authors:  Parminder J S Vig; Jinrong Wei; Qingmei Shao; Maripar E Lopez; Rebecca Halperin; Jill Gerber
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

2.  Tissue transglutaminase inhibits the TRPV5-dependent calcium transport in an N-glycosylation-dependent manner.

Authors:  Sandor Boros; Qi Xi; Henrik Dimke; Annemiete W van der Kemp; Kukiat Tudpor; Sjoerd Verkaart; Kyu Pil Lee; René J Bindels; Joost G Hoenderop
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

3.  Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.

Authors:  Scoty M Hearst; Mariper E Lopez; Qingmei Shao; Yong Liu; Parminder J S Vig
Journal:  J Neurochem       Date:  2010-04-30       Impact factor: 5.372

Review 4.  Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.

Authors:  Hyoungseok Ju; Hiroshi Kokubu; Janghoo Lim
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

5.  Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice.

Authors:  Parminder J S Vig; Qingmei Shao; S H Subramony; Mariper E Lopez; Eshan Safaya
Journal:  Cerebellum       Date:  2009-07-11       Impact factor: 3.847

Review 6.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

Review 7.  Roles of Post-translational Modifications in Spinocerebellar Ataxias.

Authors:  Linlin Wan; Keqin Xu; Zhao Chen; Beisha Tang; Hong Jiang
Journal:  Front Cell Neurosci       Date:  2018-09-19       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.